Search
for
Sort by
Research 301–330 of 1000+
- 43018 Safety Analysis of Baricitinib in Adult Patients with Severe Alopecia Areata From 2 Randomized Clinical Trials over a Median of 1.6 years and up to 3.6 Years of Exposure
- Updated Integrated Safety Analysis of Ritlecitinib Up to ~5 Years in Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- clinical trial efficacy of autologous cellular micrografts in androgenic alopecia
- LB943 Tofacitinib treatment of inflammatory skin conditions in patients with Down Syndrome
- Alopecia Areata: An Evidence-Based Treatment Update
- 9-cis-Retinoic Acid Capsules in the Treatment of AIDS-Related Kaposi Sarcoma
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Clinical and pathological evaluation of hemp seeds oil effectiveness in the treatment of alopecia areata
- Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream
- Baricitinib as the first systemic treatment for severe alopecia areata
- Randomized Controlled Trial Study to Evaluate the Efficacy of Combination Therapy with Diphenylcyclopropenone and Platelet-Rich Plasmain Alopecia Areaata
- 490 Samcyprone (diphenylcyclopropenone ointment) for the treatment of common warts
- 276 LLLT and Minoxidil combination treatment in androgenetic alopecia: A review of the literature
- 893 Low-level laser therapy for the treatment of male and female-pattern hair loss: A review of literature
- A Comparative Study of Topical Procapil With Platelet-Rich Plasma Therapy Versus Topical Redensyl, Saw Palmetto, and Biotin With Platelet-Rich Plasma Therapy in the Treatment of Androgenetic Alopecia.
- The usefulness and wellbeing of Tofacitinib in the treatment of Alopecia Areata
- Comparison of Efficacy of Various Modalities of Treatment in Patients with Androgenetic Alopecia
- Red light treatment proves safe, effective for androgenetic alopecia
- Development of Uniform Protocol for Alopecia Areata Clinical Trials
- Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial
- Treatment of black hairy tongue with triamcinolone acetonide
- Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial
- The Use of Natural Ingredients in the Treatment of Alopecias with an Emphasis on Central Centrifugal Cicatricial Alopecia: A Systematic Review.
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Response to: “Minimum requirements for reporting clinical trials evaluating the therapeutic potential of platelet-rich plasma”
- Platelet-rich plasma by single-spin process in male pattern androgenetic alopecia: Is it an effective treatment?
- Efficacy of Fire Needle Therapy Combined with Doxycycline Hydrochloride in the Management of Moderate-to-Severe Acne Vulgaris: A Randomized Controlled Trial